“Randomized phase III trial of capecitabine / cisplatin (XP) vs. continuous infusion of 5-FU / cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): efficacy and safety results”. - Kang,Y.; Kang,W. (J Clin Oncol, ASCO Annual Meeting Proceedings Part I, 2006)